Mirogabalin

DRUG7 trials

Conditions

CIPNCIPN - Chemotherapy-Induced Peripheral NeuropathyCIPN in Adjuvant Breast Cancer PatientsCentral Neuropathic PainDiabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathic Pain (DPNP)DuloxetineFibromyalgia

Phase 2

The Effectiveness of mirogabalin on peripheral neuropathy among patients treated with oxaliplatin

RecruitingJPRN-jRCT1041210094

Watanabe DaichiPeripheralneuropathicpain Chemotherapy-induced peripheral neuropathy

Start: 2021-11-01Target: 60Updated: 2026-06-29

Phase 3

Study of Mirogabalin for Central Neuropathic Pain

CompletedNCT03901352

Daiichi Sankyo Co., Ltd.Central Neuropathic Pain

Start: 2019-03-12End: 2020-12-28Updated: 2024-10-21

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain

CompletedNCT04094662

Daiichi Sankyo Co., Ltd.Diabetic Peripheral Neuropathic Pain

Start: 2019-09-18End: 2022-01-24Updated: 2022-10-24

Phase 4

Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

RecruitingNCT07451431

Bangladesh Medical UniversityDiabetic Peripheral Neuropathic Pain (DPNP)

Start: 2025-10-01End: 2027-05-01Target: 78Updated: 2026-03-09

Unknown Phase

Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA

RecruitingNCT06328062

Thammasat University HospitalOsteoarthritis, Pain Postoperative, Total Knee Arthroplasty

Start: 2024-04-01End: 2026-08-31Target: 80Updated: 2026-08-07

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

CompletedNCT06711978

Pusan National University Yangsan HospitalCIPN, CIPN - Chemotherapy-Induced Peripheral Neuropathy, CIPN in Adjuvant Breast Cancer Patients +2

Start: 2024-12-01End: 2026-04-15Updated: 2026-08-26

The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia

RecruitingNCT07157852

Beijing Tiantan HospitalFibromyalgia, Mirogabalin, Pain +1

Start: 2025-09-05End: 2027-08-31Target: 674Updated: 2026-06-25

2026-08-25

Usefulness of Mirogabalin in Central Neuropathic Pain After Stroke: Post Hoc Analysis of a Phase 3 Study by Stroke Type and Location

Pain and Therapy2024-07-04

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain.

2024-06-199 citations

Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia

Pain and Therapy2023-04-2812 citations

Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.

2022-12-1439 citations

Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study

Pain and Therapy2022-07-2034 citations